RVPH vs IQST Comparison

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

iQSTEL Inc is a technology company offering a wide array of services to the telecom and Internet industry. The business divisions of the company are Telecommunication including VoIP, SMS, International Fiber-Optic, Proprietary Internet of Things (IoT), and a Proprietary Mobile Portability Blockchain Platform; the Fintech division includes remittances services, top-up services, Master Card Debit Card, a USA Bank Account, and a Mobile App; Electric Vehicles division offers Electric Motorcycles and plans to launch a Mid Speed Car; and the Metaverse division includes Metaverse platform to access products, services, content, entertainment, information, customer support, and more in a virtual 3D interface. Geographically, it derives a majority of its revenue from the USA.